Clinical trial Recruiting at 1 site Observational Ages 19 and up

Bachmann bundle versus right atrial appendage pacing in sick sinus syndrome

Official title: Prospective Cohort Study of Bachmann Bundle Versus Right Atrial Appendage Pacing: Impact on Atrial Cardiomyopathy Evaluated by Echocardiographic Parameters and Clinical Outcome

Run by Samsung Medical Center · NCT07360067 · Data updated 2026-11-12

This research tests whether pacing the Bachmann bundle instead of the right atrial appendage reduces atrial structural and functional damage in people with sick sinus syndrome who are getting a permanent pacemaker.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment200 (estimated)
SponsorSamsung Medical Center
Academic / other
Locations1 site (Seoul, Seoul)
StatusRecruiting
StartedDecember 9, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedJuly 28, 2026
Trial IDNCT07360067 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19 years or older with sick sinus syndrome who are scheduled for de novo permanent pacemaker or implantable cardioverter-defibrillator implantation and who consent to study participation are eligible.

Probably not a fit

Patients with persistent or permanent atrial fibrillation, a life expectancy under one year, pregnant or breastfeeding women, or those who refuse active treatment are unlikely to benefit from this pacing comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center prospective observational cohort will compare patients with sick sinus syndrome who receive Bachmann bundle pacing versus conventional right atrial appendage pacing during de novo permanent pacemaker or ICD implantation. Participants will undergo baseline and serial echocardiography including left atrial size and left atrial strain measurements, with clinical follow-up to capture arrhythmias and other outcomes. Investigators will compare progression of atrial cardiomyopathy by analyzing changes in structural and functional atrial parameters and clinical event rates between the two pacing-site groups. The goal is to see whether improved interatrial conduction with Bachmann bundle pacing leads to less atrial remodeling and better clinical outcomes over time.

Why it matters

Potential benefit: If successful, this approach could preserve atrial structure and function and reduce atrial arrhythmias and related complications in paced patients.

How similar studies have gone: Prior research has reported reduced arrhythmia incidence with Bachmann bundle pacing, but effects on atrial structural and functional remodeling remain unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 19 years or older
* Patients diagnosed with sick sinus syndrome who are scheduled for de novo implantation of a permanent pacemaker or permanent implantable cardioverter-defibrillator
* Patients or their legal representatives who voluntarily consent to the access of medical records and study data throughout the entire research period

Exclusion Criteria:

* Patients with persistent or permanent AF
* Patients with a life expectancy of less than one year due to other comorbidities
* Pregnant or breastfeeding women
* Patients who refuse active treatment

Where it's running

  • Samsung Medical Center
    Seoul, Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.